FIELD: medicine.
SUBSTANCE: invention can be used for treating sterility in females suffering from hysteromyoma. For this purpose, a level of antibodies to HCG in blood serum is determined, and, if the values are from +11 % to +20 % and from -21 % to -30 %, there is prescribed a preventive treatment; when the values are above +20 % and below -30 %, surgical treatment is prescribed.
EFFECT: method allows to select the optimum therapeutic approach to sterility in females suffering from hysteromyoma; the method is safe and low cost.
1 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING HEMORRHAGES DEVELOPING IN FEMALES SUFFERING FROM HYSTEROMYOMA | 2014 |
|
RU2592374C2 |
DIAGNOSTIC TECHNIQUE FOR DETERMINING PROBABILITY OF LOCAL INFLAMMATION DEVELOPMENT IN MYOMATOUS NODULE | 2014 |
|
RU2592242C2 |
METHOD FOR EMBRYO QUALITY PREDICTION IN EXTRACORPOREAL FERTILISATION IN INFERTILE WOMEN | 2010 |
|
RU2441243C1 |
METHOD FOR PREDICTION OF THE OCCASION OF CLINICAL PREGNANCY IN IVF CYCLES IN PATIENTS WITH A PREDICTION OF SUBOPTIMALE RESPONSE TO CONTROLLED OVARIAN STIMULATION | 2022 |
|
RU2784576C1 |
METHOD FOR FORECASTING THE REGRESSION OF FOLLICULAR OVARIAN CYST FOR PATIENTS WITH INFERTILITY | 2016 |
|
RU2647785C2 |
METHOD OF PREDICTING EFFECTIVENESS OF ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS BASED ON NEURAL NETWORKS | 2022 |
|
RU2809429C1 |
METHOD FOR SELECTING FEMALE PATIENTS WITH POOR OVARIAN RESERVE FOR EGG DONATION PROGRAMME | 2014 |
|
RU2565449C1 |
METHOD OF UTERINE BLOOD FLOW IMPROVEMENT AND ENDOMETRIUM AMELIORATION IN WOMEN WITH PREVIOUS FAILURES IN EXTRACORPORAL FERTILISATION PROGRAM | 2007 |
|
RU2337726C1 |
METHOD FOR PREDICTING THE PERFORMANCE OF THE IN VITRO FERTILIZATION PROGRAM | 2017 |
|
RU2646822C1 |
METHOD OF ESTIMATION OF ACID-BASE BALANCE OF FEMALE GENITAL ORGANS (OPTIONS) | 2017 |
|
RU2666604C1 |
Authors
Dates
2016-05-27—Published
2014-11-05—Filed